1. Home
  2. Live Updates
  3. Selective inhibitor

Live Breaking News & Updates on Selective inhibitor

Stay informed with the latest breaking news from Selective inhibitor on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Selective inhibitor and stay connected to the pulse of your community

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five ratings firms that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month […]

United-states , Richarda-paulson , Michael-mason , Exchange-traded-concepts , Barclays-plc , Bleakley-financial-group , Karyopharm-therapeutics-company-profile , Sg-americas-securities , Nasdaq , Selective-inhibitor-of-nuclear-export , Capital-partners , Karyopharm-therapeutics-inc

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , San-diego , California , American , Henrye-pelish , Henry-pelish , Joshuac-horan , Tuanm-nguyen , Franklin-gu

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., April 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an...

United-kingdom , China , Nasdaq , Prnewswire-karyopharm-therapeutics-inc , Karyopharm-therapeutics-inc , Selective-inhibitor-of-nuclear-export , Linkedin , Stock-incentive-plan , Nasdaq-listing-rule , Selective-inhibitor , Nuclear-export

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , China , Linkedin , Selective-inhibitor-of-nuclear-export , Prnewswire-karyopharm-therapeutics-inc , Nasdaq , Karyopharm-therapeutics-inc , Stock-incentive-plan , Nasdaq-listing-rule , Selective-inhibitor , Nuclear-export

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress

Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states , Boston , Massachusetts , Macau , Singapore , United-kingdom , Sadal , Kyongsang-bukto , South-korea , Seoul , Soult-ukpyolsi , Hong-kong

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Shares Acquired by Silverarc Capital Management LLC

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Shares Acquired by Silverarc Capital Management LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Piper-sandler , Nasdaq , Exchange-commission , Royal-bank , Selective-inhibitor-of-nuclear-export , Silverarc-capital-management , Bleakley-financial-group , Prelude-capital-management , Karyopharm-therapeutics-inc , Advisor-group-holdings-inc , Karyopharm-therapeutics

Silverarc Capital Management LLC Has $753,000 Position in Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Silverarc Capital Management LLC Has $753,000 Position in Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Virginia , United-states , Canada , Piper-sandler , Selective-inhibitor-of-nuclear-export , Silverarc-capital-management , Nasdaq , Royal-bank , Barclays-plc , Securities-exchange-commission , Karyopharm-therapeutics-company-profile , Exchange-traded-concepts

Wade G W & Inc. Purchases New Position in Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Wade G W & Inc. Purchases New Position in Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Canada , Piper-sandler , Selective-inhibitor-of-nuclear-export , Pricet-rowe-associates-inc , Wadegw-inc , Northern-trust-corp , Karyopharm-therapeutics-inc , Royal-bank , Nasdaq , Advisor-group-holdings-inc

Karyopharm Therapeutics Inc. (KPTI) Stock Price | Stock Quote Nasdaq

Karyopharm Therapeutics Inc. (KPTI.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Karyopharm Therapeutics Inc. | Nasdaq: KPTI | Nasdaq

Selective-inhibitor-of-nuclear-export , Karyopharm-therapeutics-inc , Karyopharm-therapeutics , Selective-inhibitor , Nuclear-export , Karyopharm-therapeutics-inc-quotes , Tock-quote , Tock , Pti , S48576u1060 , Asdaq

Karyopharm Therapeutics (NASDAQ:KPTI) Share Price Crosses Below Two Hundred Day Moving Average of $1.15

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.15 and traded as low as $0.69. Karyopharm Therapeutics shares last traded at $0.77, with a volume of 1,320,715 shares changing hands. Wall Street Analysts Forecast Growth KPTI […]

Texas , United-states , Canada , Piper-sandler , Karyopharm-therapeutics-inc , Nasdaq , Selective-inhibitor-of-nuclear-export , Advisor-group-holdings-inc , Royal-bank , Northern-trust-corp , Pricet-rowe-associates-inc , Karyopharm-therapeutics